Abstract
In this paper authors present two cases of multiple schwannomas without the features of neurofibromatosis (NF). The authors retrospectively reviewed the hospital charts, radiology films, operative notes and pathology slides of these two patients. There was no family history of neurofibromatosis. The two patients had contrast enhanced MRI, which was negative for vestibular schwannomas. Both underwent surgical excision of symptomatic lesions. Histopathology confirmed these lesions as schwannomas. Molecular genetic analysis in case 1 demonstrated two distinct mutations of the NF2 gene in two different schwannomas, with concomitant loss of heterozygosity in both tumours. In contrast peripheral blood lymphocytes did not reveal mutations of NF2. The authors recommend surgery for symptomatic lesions. Asymptomatic tumours can be monitored. Regular follow up is essential as they may develop fresh lesions at any time. The relevant literature is discussed.
References
Barre PS, Shaffer JW, Carter JR et al (1987) Multiplicity of neurilemmomas in the upper extremity. J Hand Surg (Am) 12:307–311
Daras M, Koppel BS, Heise CW et al (1993) Multiple spinal intradural schwannomas in the absence of Von Recklinghausens disease. Spine 18:2556–2559
Donner TR, Voorhies RM, Kline DG (1994) Neural sheath tumours of major nerves. J Neurosurg 81:362–373
Enzinger FM, Weiss SW (1988) Soft tissue tumours, 2d edn. Mosby, St. Louis, pp 724–815
Evans DGR, Huson SM, Donnai D et al (1992) A clinical study of type 2 neurofibromatosis. Q J Med 84:603–618
Evans DGR, Mason S, Huson SM et al (1997) Spinal and cutaneous Schwannomatosis is a variant form of type 2 neurofibromatosis: a clinical and molecular study. J Neurol Neurosurg Psychiatry 62:361–366
Gutman DH (1997) Molecular insights into neurofibromatosis 2 gene. Neuro Biol Dis 3:247–261
Gutman DH (2001) The neurofibromatosis: when less is more. Hum Mol Genet 10:747–755
Gutman DH, Aylsworth A, Carey JC et al (1997) The diagnostic evaluation and multidisciplinary management of neurofibromatosis 1 and neurofibromatosis 2. JAMA 278:51–57
Haariada S, Nerlich AG, Bise K et al (1992) Comparison of various basement membrane components in benign and malignant speripheral nerve tumours. Virchows Arch A Pathol Anat Histopathol 421:331–338
Halliday AL, Sobel RA, Martuza RL (1991) Benign spinal nerve sheath tumours: their occurrence sporadically and in neurofibromatosis types 1 and 2. J Neurosurg 74:248–253
Huang JH, Simon SL, Seema Nagpal SB et al (2004) Management of patients with Schwannomatosis: report of six cases and review of literature. Surg Neurol 62:353–361
Jacoby LB, Jones D, Davis K et al (1997) Molecular analysis of NF2 tumour suppressor gene in Schwannomatosis. Am J Hum Genet 61:1293–1302
MacCollin M, Woodfin W, Kronn D, Short MP (1996) Schwannomatosis: a clinical and pathologic study. Neurology 46:1072–1079
MacCollin M, Willet C, Heinrich B et al (2003) Familial Schwannomatosis. Exclusion of the NF2 locus as the germ line event. Neurology 60:1968–1974
MacCollin M, Chicocca EA, Evans DG et al (2005) Diagnostic criteria for schwannomatosis. Neurology 64:1838–1845
Mautner VF, Tatagiba M, Guthoff R, Samii M, Pulst SM (1993) Neurofibromatosis in the pediatric age group. Neurosurgery 33:92–96
Michael EB, Friedman JM, Gareth D, Evans R (2006) Increasing the specificity of diagnostic criteria for schwannomatosis. Neurology 66:730–732
Mulvihill JJ, Parry DM, Shermann JL et al (1990) NIH conference. Neurofibromatosis 1 and neurofibromatosis 2. An update. Ann Intern Med 113:39–52
NIH (1988) Neurofibromatosis, Conference statement, National institutes of health consensus development conference. Arch Neurol 45:575–578
Nimura M (1973) Neurofibromatosis. Rinsho Derma 15:653–663
Parry DM, Eldridge R, Kaiser Kupfer M, Bouzas EA, Pikus A, Patronas N (1994) Neurofibromatosis 2: clinical characteristics of 63 affected individuals and clinical evidence for heterogenecity. Am J Genet 52:450–461
Parry DM, MacCollin M, Kaiser-Kupfer MI et al (1996) Germ line mutations in the neurofibromatosis 2 gene: correlation with disease severity and retinal abnormalities. Am J Hum Genet 59:529–539
Poliani PL, DeSantis S, Bettensky RA et al (2005) Defining histologic criteria for the diagnosis of schwannomatosis, Aspen, CO, June 5–8
Purcell SM, Dixon SL, Schwannomatosis (1989) An unusual variant of neurofibromatosis or a distinct clinical entity. Arch Dermatol 125:390–393
Riccardi VM (1981) Von Recklinghausen neurofibromatosis. N Engl J Med 305:1617–1627
Rouleau GA, Merel P, Lutchman M et al (1993) Alteration in new gene encoding a putative membrane-organizing protein causes neurofibromatosis 2. Nature 363:515–521
Ruggieri M (1999) The different forms of neurofibromatosis. Childs Nerv Syst 15:295–308
Seppala MT, Saino MA, Haltia MJ et al (1998) Multiple schwannomas: Schwannomatosis or neurofibromatosis 2. J Neurosurg 89:36–41
Shin KH, Moon SH, Suh JS et al (1998) Multiple neurilemomas. A case report. Clin Orthop 171:5
Trofatter JA, Mac Collin MM, Rutter JL et al (1993) A novel moesin-, ezrin-, radixin-like gene is a candidate for the neurofibromatosis 2 suppressor. Cell 72:791–800
Wolkenstein P, Benchikhi H, Zeller J et al (1997) Schwannomatosis: a clinical entity distinct from neurofibromatosis 2. Dermatology 195:228–231
Woodruff JM, Godwin TA, Erlandson RA et al (1981) Cellular schwannoma: a variety of schwannoma some times mistaken for malignant tumour. Am J Surg Pathol 5:733–744
Yamamoto T, Maruyama S, Mizuno K (2001) Schwannomatosis of sciatic nerve. Skeletal Radiol 30:109–113
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Javalkar, V.K., Pigott, T., Pal, P. et al. Multiple schwannomas: report of two cases. Eur Spine J 16 (Suppl 3), 287–292 (2007). https://doi.org/10.1007/s00586-006-0303-9
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00586-006-0303-9